Absci (ABSI) Non-Current Assets (2020 - 2026)
Absci (ABSI) reported Non-Current Assets of $63.6 million for Q1 2026, down 16.8% on a YoY basis from $76.5 million in Q1 2025, and down 4.65% sequentially from $66.7 million in Q4 2025.
Absci (ABSI) Non-Current Assets (2020 - 2026) Analysis & Trends
Absci (ABSI) has 7 years of Non-Current Assets data on file, last reported at $63.6 million in Q1 2026.
- For the quarter ending Q1 2026, Non-Current Assets fell 16.8% year-over-year to $63.6 million; the trailing twelve-month figure through Mar 2026 stood at $272.8 million (down 17.74% YoY), and the FY2025 full-year result was $66.7 million, down 16.36% from the prior year.
- Non-Current Assets declined to $63.6 million in Q1 2026, from $66.7 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $139.5 million in Q1 2022 to a low of $63.6 million in Q1 2026.
- A 5-year average of $99.0 million and a median of $93.1 million in 2024 frame the typical range for Non-Current Assets.
- Across the five-year window, Non-Current Assets declined 4.32% in 2022 and decreased 28.65% in 2024, its largest moves.
- Tracing ABSI's Non-Current Assets over 5 years: stood at $134.1 million in 2022, then decreased by 27.9% to $96.7 million in 2023, then dropped by 17.52% to $79.8 million in 2024, then slipped by 16.36% to $66.7 million in 2025, then fell by 4.65% to $63.6 million in 2026.
- Business Quant data shows ABSI's Non-Current Assets at $63.6 million in Q1 2026, $66.7 million in Q4 2025, and $70.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 21.65 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 5.83 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.95 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 3.95 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.75 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.66 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.96 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 285.82 Mn |
| 10 | Absci | 1.23 Bn | 1.11 Bn | - | 63.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 63.62 Mn |
| Dec 31, 2025 | 66.72 Mn |
| Sep 30, 2025 | 70.00 Mn |
| Jun 30, 2025 | 72.49 Mn |
| Mar 31, 2025 | 76.47 Mn |
| Dec 31, 2024 | 79.78 Mn |
| Sep 30, 2024 | 85.09 Mn |
| Jun 30, 2024 | 90.34 Mn |
| Mar 31, 2024 | 93.10 Mn |
| Dec 31, 2023 | 96.72 Mn |
| Sep 30, 2023 | 101.63 Mn |
| Jun 30, 2023 | 106.12 Mn |
| Mar 31, 2023 | 130.49 Mn |
| Dec 31, 2022 | 134.15 Mn |
| Sep 30, 2022 | 138.01 Mn |
| Jun 30, 2022 | 138.43 Mn |
| Mar 31, 2022 | 139.50 Mn |
| Dec 31, 2021 | 153.12 Mn |
| Sep 30, 2021 | 148.45 Mn |
| Jun 30, 2021 | 144.68 Mn |